ark therapeutics group plc (AKT:London)
Seppo Yla-Herttuala M.D., Ph.D., FESC
Member of Scientific Advisory Board, TaxuCardium Pharmaceuticals Group Inc.
|Age||Total Calculated Compensation||This person is connected to 26 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Prof. Seppo Yla-Herttuala M.D., Ph.D. is Professor of Molecular Medicine for A.I. Virtanen Institute for Molecular Sciences and Department of Medicine, University of Kuopio, Kuopio, Finland. Dr. Yla-Herttuala is an Internationally Recognized Leader in cardiovascular gene therapy. His team was among the first to use adenovirus-mediated gene transfer in human arteries and since then, he has conducted several clinical trials in cardiovascular gene therapy. His group is ...
85 Tottenham Court RoadPhone: 44 2037 555 160
London, Greater London W1T 4TQ
Board Members Memberships*
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|